{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.72","upperLimit":"0.95","value":"0.87"},{"groupId":"OG001","lowerLimit":"0.73","upperLimit":"0.96","value":"0.89"}]}],"title":"1 year"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.49","upperLimit":"0.80","value":"0.67"},{"groupId":"OG001","lowerLimit":"0.41","upperLimit":"0.75","value":"0.60"}]}],"title":"2 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.42","upperLimit":"0.75","value":"0.61"},{"groupId":"OG001","lowerLimit":"0.36","upperLimit":"0.71","value":"0.56"}]}],"title":"3 years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"PFS rate is defined as the percentage of participants who have neither progressed nor died at the specified timepoints","dispersionType":"95% Confidence Interval","groups":[{"description":"Lenalidomide\n\n25 mg taken orally once daily, Days 1 - 21 of each cycle\n\nDexamethasone\n\nAdministered on Days 1, 8, 15, and 22 of each cycle:\n\nOn weeks when elotuzumab is administered:\n\n* 28 mg taken orally (3 - 24 hours prior to start of elotuzumab infusion) AND\n* 8 mg IV (at least 45 minutes prior to elotuzumab administration)\n\nOn weeks when elotuzumab is NOT administered:\n\n\\- 40 mg taken orally\n\nElotuzumab (BMS-901608)\n\n* Cycle 1 - 2: 10 mg/kg IV, Days 1, 8, 15, 22\n* Cycle 3 - 18: 10 mg/kg IV, Days 1 and 15\n* Cycle 19 and beyond: 20 mg/kg IV, Day 1","id":"OG000","title":"Arm A: Lenalidomide + Dexamethasone + Elotuzumab (BMS-901608)"},{"description":"Lenalidomide\n\n25 mg taken orally once a day, Days 1 - 21 of each cycle\n\nDexamethasone\n\n40 mg taken orally, Days 1, 8, 15, and 22 of each cycle","id":"OG001","title":"Arm B: Lenalidomide + Dexamethasone"}],"paramType":"NUMBER","populationDescription":"All randomized participants","reportingStatus":"POSTED","timeFrame":"From randomization up to the specified timepoints, up to 3 years","title":"Progression Free Survival (PFS) Rate","type":"SECONDARY","unitOfMeasure":"Percentage of Participants"}